Unfortunately we both know it isn't an easy task.

Unfortunately we both know it isn't an easy task. But all you need is one good catalyst and some well placed PR and bingo. One outside the box strategy would be if various BPs who would benefit from Lympro along with ICON simultaneously release PRs about LYMPRO and how it will help refocus the fight against ALZ with better screening. That would be cost effective and powerful and would hopefully get the medias attention when several companies all tout one diagnostic. I don't see that happening but would definitely be fun to see.

My Agenda: To see Amarantus prosper so I can make a nice return on my investment.